Search Results - "Saunders, Catherine A.B"

Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer by Saunders, Catherine A.B, Dussek, Julian E, O’Doherty, Michael J, Maisey, Michael N

“…Background. Surgical resection of lung cancer remains the treatment of choice in appropriately staged disease, but conventional imaging techniques have…”
Get full text

[18F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer by Dhital, Kumud, Saunders, Catherine A.B., Seed, Paul T., O'Doherty, Michael J., Dussek, Julian

“…Objective: Positron emission tomography (PET) is being increasingly used as an accurate and non-invasive modality in diagnosis, staging and post-therapy…”
Get full text

Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy by Kong, Benjamin Y., Menzies, Alexander M., Saunders, Catherine A. B., Liniker, Elizabeth, Ramanujam, Sangeetha, Guminski, Alex, Kefford, Richard F., Long, Georgina V., Carlino, Matteo S.

“…Summary 18‐Fluorodeoxyglucose positron emission tomography (FDG‐PET) scans were performed on 27 patients with unresectable stage IIIC or IV melanoma after…”
Get full text

Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanoma by Carlino, Matteo S, Gowrishankar, Kavitha, Saunders, Catherine A B, Pupo, Gulietta M, Snoyman, Stephanie, Zhang, Xu Dong, Saw, Robyn, Becker, Therese M, Kefford, Richard F, Long, Georgina V, Rizos, Helen

“…Inhibitors of the mitogen-activated protein kinases (MAPK), BRAF, and MAP-ERK kinase (MEK) induce tumor regression in the majority of patients with BRAF-mutant…”
Get full text

New RAS-mutant pancreatic adenocarcinoma with combined BRAF and MEK inhibition for metastatic melanoma by Carlino, Matteo S, Kwan, Vu, Miller, David K, Saunders, Catherine A B, Yip, Desmond, Nagrial, Adnan M, Tomlinson, Jeanne, Grimmond, Sean M, Scolyer, Richard A, Kefford, Richard F, Biankin, Andrew V, Long, Georgina V

Get full text

18F-labelled fluorodeoxyglucose–positron emission tomography (FDG–PET) heterogeneity of response is prognostic in dabrafenib treated BRAF mutant metastatic melanoma by Carlino, Matteo S., Saunders, Catherine A.B., Haydu, Lauren E., Menzies, Alexander M., Martin Curtis, C., Lebowitz, Peter F., Kefford, Richard F., Long, Georgina V.

“…Little is known about the prevalence and clinical significance of heterogeneity of positron emission tomography with 18F-labelled fluorodeoxyglucose–positron…”
Get full text

(18)F-labelled fluorodeoxyglucose-positron emission tomography (FDG-PET) heterogeneity of response is prognostic in dabrafenib treated BRAF mutant metastatic melanoma by Carlino, Matteo S, Saunders, Catherine A B, Haydu, Lauren E, Menzies, Alexander M, Martin Curtis, Jr, C, Lebowitz, Peter F, Kefford, Richard F, Long, Georgina V

“…Little is known about the prevalence and clinical significance of heterogeneity of positron emission tomography with (18)F-labelled fluorodeoxyglucose-positron…”
Get full text

Detection of Lymphoma in Bone Marrow by Whole-Body Positron Emission Tomography by Carr, Robert, Barrington, Sally F., Madan, Bella, O'Doherty, Michael J., Saunders, Catherine A.B., van der Walt, Jon, Timothy, Adrian R.

“…Positron emission tomography (PET) is a whole-body imaging technique using 18 fluorine-fluorodeoxyglucose (FDG), whose uptake is increased in tumor cells…”
Get full text

18 F-labelled fluorodeoxyglucose–positron emission tomography (FDG–PET) heterogeneity of response is prognostic in dabrafenib treated BRAF mutant metastatic melanoma by Carlino, Matteo S, Saunders, Catherine A.B, Haydu, Lauren E, Menzies, Alexander M, Martin Curtis, C, Lebowitz, Peter F, Kefford, Richard F, Long, Georgina V

“…Abstract Background Little is known about the prevalence and clinical significance of heterogeneity of positron emission tomography with18 F-labelled…”
Get full text

Assessment of pediatric hydronephrosis using output efficiency by SAUNDERS, C. A. B, CHOONG, K. K. L, LARCOS, G, FARLOW, D, GRUENEWALD, S. M

“…Diagnosing obstruction in pediatric patients with hydronephrosis, and renal impairment is often difficult. Renal output efficiency (OE) is a parameter that may…”
Get full text

Detection of lymphoma in bone marrow by whole-body positron emission tomography by CARR, R, BARRINGTON, S. F, MADAN, B, O'DOHERTY, M. J, SAUNDERS, C. A. B, VAN DER WALT, J, TIMOTHY, A. R

“…Positron emission tomography (PET) is a whole-body imaging technique using 18 fluorine-fluorodeoxyglucose (FDG), whose uptake is increased in tumor cells…”
Get full text